In the last trading session, 4.3 million Bio-Key International Inc (NASDAQ:BKYI) shares changed hands as the company’s beta touched 0.00. With the company’s per share price at $1.50 changed hands at $0.06 or 4.17% during last session, the market valuation stood at $4.69M. BKYI’s last price was a discount, traded about -114.67% off its 52-week high of $3.22. The share price had its 52-week low at $0.52, which suggests the last value was 65.33% up since then. When we look at Bio-Key International Inc’s average trading volume, we note the 10-day average is 1.75 million shares, with the 3-month average coming to 2.28 million.
Bio-Key International Inc (NASDAQ:BKYI) trade information
Instantly BKYI was in green as seen at the end of in last trading. With action 7.91%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -12.28%, with the 5-day performance at 7.91% in the green. However, in the 30-day time frame, Bio-Key International Inc (NASDAQ:BKYI) is 36.36% up. Looking at the short shares, we see there were 0.87 million shares sold at short interest cover period of 0.16 days.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 2.29M. 1 analysts are of the opinion that Bio-Key International Inc’s revenue for the current quarter will be 2.5M.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 32.10%. The 2025 estimates are for Bio-Key International Inc earnings to increase by 83.76%.
BKYI Dividends
Bio-Key International Inc is expected to release its next quarterly earnings report in February.
Bio-Key International Inc (NASDAQ:BKYI)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 5.57% of Bio-Key International Inc shares while 9.26% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 9.81%.
Among Mutual Funds, the top two as of Nov 30, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . With 8.55 shares estimated at $12828.0 under it, the former controlled 0.27% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.21% of the shares, roughly 6.65 shares worth around $9979.0.
